137 related articles for article (PubMed ID: 3526756)
1. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
[TBL] [Abstract][Full Text] [Related]
2. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
3. The leukocyte adherence inhibition test (LAI) in preoperative diagnosis of epithelial ovarian cancer.
Dgani R; Shani A; Elchalal U; Harpaz N; Bentwich Z; Fink A
Gynecol Oncol; 1993 Jun; 49(3):349-53. PubMed ID: 8314537
[TBL] [Abstract][Full Text] [Related]
4. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
5. Humoral leukocyte adherence inhibition (H-LAI) with basic encephalitogenic protein (BEP) in head and neck cancer.
Kövesi G; Fekete B
Haematologia (Budap); 1985; 18(1):27-32. PubMed ID: 2581853
[TBL] [Abstract][Full Text] [Related]
6. [The use of the determination of the immune competence of patients with malignant tumors of the maxillofacial area for making a diagnosis and prognosis].
Teuber S; Köhler M
Zahn Mund Kieferheilkd Zentralbl; 1989; 77(7):692-7. PubMed ID: 2532830
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
Storch H; Granetzny A
Z Gesamte Inn Med; 1987 Jan; 42(2):41-4. PubMed ID: 3554795
[TBL] [Abstract][Full Text] [Related]
8. Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer.
Kubasova T; Bank J; Köteles GJ; Horváth M
Neoplasma; 1990; 37(2):173-8. PubMed ID: 2188164
[TBL] [Abstract][Full Text] [Related]
9. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
10. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
[TBL] [Abstract][Full Text] [Related]
11. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
Horváth M; Tóth L; Tóth J; Fekete B
Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
13. Application of tube LAI assay in larynx cancer patients.
Hasek M; Holán V; Síbl O; Kousalová M
Neoplasma; 1981; 28(6):685-8. PubMed ID: 7040994
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
15. Immunological response of patients with tumors of the urogenital tract: a follow-up of cell-mediated antitumor immunity by the LAI test.
Holán V; Heyberger K; Bubeník J; Hasek M; Kanka J; Laurová L
Neoplasma; 1977; 24(1):71-9. PubMed ID: 320490
[TBL] [Abstract][Full Text] [Related]
16. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
Mounielou PM; Clemente F; Estival A; Ribet A
Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
[TBL] [Abstract][Full Text] [Related]
18. Immuno-diagnosis of ovarian cancer by the aid of cell-mediated immunologic techniques.
Ueda K; Toyokawa M; Nakamori H; Sako H; Umesaki N; Nakade J; Lee T; Sugawa T
Osaka City Med J; 1977; 23(1):73-84. PubMed ID: 345183
[No Abstract] [Full Text] [Related]
19. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]